Search results
Results From The WOW.Com Content Network
Prior to the UK's departure from the European Union in January 2021, the MHRA was part of the European system of approval. Under this system, national bodies can be the rapporteur or co-rapporteur for any given pharmaceutical application, taking on the bulk of the verification work on behalf of all members, while the documents are still sent to ...
The Central Drugs Standard Control Organisation (CDSCO) is India's national regulatory body for cosmetics, pharmaceuticals and medical devices.It serves a similar function to the Food and Drug Administration (FDA) of the United States or the European Medicines Agency of the European Union.
A stringent regulatory authority is a regulatory authority which is: a) a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), being the European Commission, the US Food and Drug Administration and the Ministry of Health, Labour and Welfare of Japan also represented by the Pharmaceuticals and Medical Devices Agency (as before ...
Help; Learn to edit; Community portal; Recent changes; Upload file; Special pages
Three subordinate offices: Central Hindi Directorate (CHD), New Delhi; Commission for Scientific & Technological Terminology (CSTT), New Delhi; and Central Institute of Indian Languages (CIIL), Mysore
In most countries, a marketing authorisation is valid for a period of 5 years. After this period, one should apply for renewal of the marketing authorisation, usually by providing minimal data proving that quality, efficacy and safety characteristics are maintained and the risk-benefit ratio of the medicinal product is still favourable.
Australian Council on Healthcare Standards International (ACHSI) [7] Australian General Practice Accreditation Limited (AGPAL) [8] Australian Commission on Safety and Quality in Health Care (ACSQHC) [9] uses standards developed by the National Safety and Quality Health Service Standards (NSQHS Standards) [10]
Dr. VG Somani succeeded S Eswara Reddy, the interim DCGI who was appointed in February 2018. DCGI heads the Indian drug regulatory body the Central Drugs Standard Control Organisation (CDSCO), whose functions include ensuring the quality of drugs and cosmetics sold in the country, approval of new drugs and regulating clinical trials. [3] [4]